Sign In
Buy IART
$16.10
+0.430 (+2.74%)
At Close: Jun 03, 2026
Integra (IART) Reports Q3 Earnings: What Key Metrics Have to Say
10:31am, Monday, 04'th Nov 2024
While the top- and bottom-line numbers for Integra (IART) give a sense of how the business performed in the quarter ended September 2024, it could be worth looking at how some of its key metrics compa
Integra LifeSciences (IART) Beats Q3 Earnings and Revenue Estimates
08:16am, Monday, 04'th Nov 2024
Integra LifeSciences (IART) came out with quarterly earnings of $0.41 per share, beating the Zacks Consensus Estimate of $0.39 per share. This compares to earnings of $0.76 per share a year ago.
Integra LifeSciences Reports Third Quarter 2024 Financial Results
06:03am, Monday, 04'th Nov 2024
PRINCETON, N.J., Nov. 04, 2024 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, today reported financial results for the thir
Integra LifeSciences Announces Appointment of Mojdeh Poul as President and Chief Executive Officer
06:00am, Monday, 04'th Nov 2024
A proven healthcare executive with deep global expertise and a distinguished record in business strategy and execution, portfolio transformation, value-creating innovation, commercial excellence, and
Integra LifeSciences to Host Third Quarter 2024 Financial Results Conference Call on November 4, 2024
08:00am, Monday, 14'th Oct 2024
PRINCETON, N.J., Oct. 14, 2024 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, will release third quarter 2024 financial re
Here's Why You Should Hold IART Stock in Your Portfolio Now
10:05am, Friday, 04'th Oct 2024
Integra's strong growth in the Tissue Technologies and CSS business segment bolsters investors' confidence in the stock.
Integra LifeSciences to Present at the 22nd Annual Morgan Stanley Healthcare Conference
04:01pm, Wednesday, 04'th Sep 2024
PRINCETON, N.J., Sept. 04, 2024 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, announced today that Lea Knight, chief fina
Integra LifeSciences to Present at the 2024 Wells Fargo Healthcare Conference
10:32am, Wednesday, 04'th Sep 2024
PRINCETON, N.J., Sept. 04, 2024 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, announced today that Lea Knight, chief fina
Integra LifeSciences Continues to Make Progress on Its ESG Strategy
04:15pm, Wednesday, 21'st Aug 2024
The company published its third ESG report, underscoring its values and commitment to restoring lives The company published its third ESG report, underscoring its values and commitment to restoring li
Integra's (IART) Q2 Earnings and Revenues Top, Margins Down
01:51pm, Tuesday, 30'th Jul 2024
Integra's (IART) second-quarter 2024 results reflect strong demand for its diverse portfolio of leading brands and the continued successful market adoption of CereLink.
Integra LifeSciences Analysts Cut Their Forecasts After Q2 Results
11:36am, Tuesday, 30'th Jul 2024
Integra LifeSciences IART reported upbeat second-quarter earnings and lowered its FY24 guidance below estimates on Monday.
Why Integra Lifesciences Stock Is Sinking Today
12:23pm, Monday, 29'th Jul 2024
Integra Lifesciences topped analysts' Q2 revenue and earnings estimates. However, the company reduced its full-year guidance.
Compared to Estimates, Integra (IART) Q2 Earnings: A Look at Key Metrics
10:31am, Monday, 29'th Jul 2024
While the top- and bottom-line numbers for Integra (IART) give a sense of how the business performed in the quarter ended June 2024, it could be worth looking at how some of its key metrics compare to
Abbott, Integra LifeSciences And Other Big Stocks Moving Lower In Monday's Pre-Market Session
08:24am, Monday, 29'th Jul 2024
U.S. stock futures were higher this morning, with the Dow futures gaining around 150 points on Monday.
Integra LifeSciences (IART) Q2 Earnings and Revenues Surpass Estimates
08:16am, Monday, 29'th Jul 2024
Integra LifeSciences (IART) came out with quarterly earnings of $0.63 per share, beating the Zacks Consensus Estimate of $0.62 per share. This compares to earnings of $0.71 per share a year ago.
